Your browser doesn't support javascript.
loading
Estimating Annual Fluctuations in Malaria Transmission Intensity and in the Use of Malaria Control Interventions in Five Sub-Saharan African Countries.
Adeniji, Elisha; Asante, Kwaku Poku; Boahen, Owusu; Compaoré, Guillaume; Coulibaly, Boubacar; Kaali, Seyram; Kabore, Youssouf; Lamy, Mathieu; Lusingu, John; Malabeja, Anangisye; Mens, Petra; Orsini, Mattéa; Otieno, Lucas; Otieno, Walter; Owusu-Agyei, Seth; Oyieko, Janet; Pirçon, Jean-Yves; Praet, Nicolas; Roman, François; Sie, Ali; Sing'oei, Valentine; Sirima, Sodiomon B; Sylla, Khadime; Tine, Roger; Tiono, Alfred B; Tivura, Mathilda; Usuf, Effua; Wéry, Stéphanie.
Afiliação
  • Adeniji E; Kintampo Health Research Centre, Ghana Health Service, Kintampo, Ghana.
  • Asante KP; Kintampo Health Research Centre, Ghana Health Service, Kintampo, Ghana.
  • Boahen O; Kintampo Health Research Centre, Ghana Health Service, Kintampo, Ghana.
  • Compaoré G; Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
  • Coulibaly B; Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
  • Kaali S; Kintampo Health Research Centre, Ghana Health Service, Kintampo, Ghana.
  • Kabore Y; Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Ouagadougou, Burkina Faso.
  • Lamy M; Aixial c/o GSK, Wavre, Belgium.
  • Lusingu J; University of Copenhagen, Copenhagen, Denmark.
  • Malabeja A; National Institute for Medical Research (NIMR), Korogwe, Tanzania.
  • Mens P; National Institute for Medical Research (NIMR), Korogwe, Tanzania.
  • Orsini M; Parasitology Unit, Department of Medical Microbiology, Academic Medical Center, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Otieno L; 4Clinics c/o GSK, Wavre, Belgium.
  • Otieno W; KEMRI - Walter Reed Project, US Army Medical Research Directorate-Kenya, Kombewa, Kenya.
  • Owusu-Agyei S; KEMRI - Walter Reed Project, US Army Medical Research Directorate-Kenya, Kombewa, Kenya.
  • Oyieko J; Kintampo Health Research Centre, Ghana Health Service, Kintampo, Ghana.
  • Pirçon JY; KEMRI - Walter Reed Project, US Army Medical Research Directorate-Kenya, Kombewa, Kenya.
  • Praet N; GSK, Wavre, Belgium.
  • Roman F; GSK, Wavre, Belgium.
  • Sie A; GSK, Wavre, Belgium.
  • Sing'oei V; Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
  • Sirima SB; KEMRI - Walter Reed Project, US Army Medical Research Directorate-Kenya, Kombewa, Kenya.
  • Sylla K; Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Ouagadougou, Burkina Faso.
  • Tine R; Département de Parasitologie, Centre de Recherche de Keur Socé, Faculté de Médecine, Université Cheikh Anta Diop, Dakar, Senegal.
  • Tiono AB; Département de Parasitologie, Centre de Recherche de Keur Socé, Faculté de Médecine, Université Cheikh Anta Diop, Dakar, Senegal.
  • Tivura M; Centre National de Recherche et de Formation sur le Paludisme (CNRFP), Ouagadougou, Burkina Faso.
  • Usuf E; Kintampo Health Research Centre, Ghana Health Service, Kintampo, Ghana.
  • Wéry S; Medical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Am J Trop Med Hyg ; 103(5): 1883-1892, 2020 11.
Article em En | MEDLINE | ID: mdl-32959764
ABSTRACT
RTS,S/AS01E malaria vaccine safety, effectiveness, and impact will be assessed in pre- and post-vaccine introduction studies, comparing the occurrence of malaria cases and adverse events in vaccinated versus unvaccinated children. Because those comparisons may be confounded by potential year-to-year fluctuations in malaria transmission intensity and malaria control intervention usage, the latter should be carefully monitored to adequately adjust the analyses. This observational cross-sectional study is assessing Plasmodium falciparum parasite prevalence (PfPR) and malaria control intervention usage over nine annual surveys performed at peak parasite transmission. Plasmodium falciparum parasite prevalence was measured by microscopy and nucleic acid amplification test (quantitative PCR) in parallel in all participants, and defined as the proportion of infected participants among participants tested. Results of surveys 1 (S1) and 2 (S2), conducted in five sub-Saharan African countries, including some participating in the Malaria Vaccine Implementation Programme (MVIP), are reported herein; 4,208 and 4,199 children were, respectively, included in the analyses. Plasmodium falciparum parasite prevalence estimated using microscopy varied between study sites in both surveys, with the lowest prevalence in Senegalese sites and the highest in Burkina Faso. In sites located in the MVIP areas (Kintampo and Kombewa), PfPR in children aged 6 months to 4 years ranged from 24.8% to 27.3%, depending on the study site and the survey. Overall, 89.5% and 86.4% of children used a bednet in S1 and S2, of whom 68.7% and 77.9% used impregnated bednets. No major difference was observed between the two surveys in terms of PfPR or use of malaria control interventions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article